Saturday, January 14, 2017

Jason Chaffetz (R-Utah) provides a distraction from Tom Price's ethical lapses

Front page news

Quoted in Head of Ethics Office Speaks Out. Some Republicans Ask, Was It Ethical?  (The New York Times, 1/13/201)

On another front, you should know that on January 3, 2017, Chaffetz voted to strip the Office of Congressional Ethics of its independence.  
From the Salt Lake Tribune.  Chaffetz, chairman of the House Oversight and Government Reform Committee that probes potential wrongdoing in the executive branch, said it was clear the OCE needed to be reformed to ensure better due process for those who might fall under investigation. He also said oversight from the Ethics Committee was important to ensure integrity because it is made up of four Republicans and four Democrats no matter who has the majority in the House.

Page 10 news

Australian Drug Maker Has Low Profile but Powerful Backers in Washington.  (The New York Times, 1132017)

On 4 occasions in 2015 and 2016, Price purchased shares of Innate, a small, obscure drug company with no track records, of between $60,000 and $110,000.  He is one of a number of D.C. power brokers who has a puzzling interest in a 'no-name Australian biotech.'

Other Chaffetz posts:
The 3 contenders for Speaker of the House speak out on same-sex marriage.  (10/7/2015)
The 3 contenders for Speaker of the House speak out on climate change.  (10/6/2017)
Meet the Members of the Republican Study Committee.  (8/14/2015)
\No friend to the environment.  (5/20/2015)

Other Price posts:
Meet the Members of the Republican Study Committee.  (7/7/2015)
No friend to the environment.  (12/13/2014)

No comments: